1)Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228-1233, 1990
2)Eaden JA, Abrams KR, Maybery JF. The risk of colorectal cancer in ulcerative colitis:a meta-analysis. Gut 48:526-535, 2001
3)Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease:a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res 9:887-894, 2016
4)Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease:standardized classification with provisional clinical applications. Hum Pathol 14:931-968, 1983
5)田中宏幸,藤盛孝博,安田是和.IBD dysplasia/cancer.八尾隆史,藤盛孝博(編).腫瘍病理鑑別診断アトラス 大腸癌.文光堂,pp 148-155, 2011
6)武藤徹一郎,若狭治毅,喜納勇,他.潰瘍性大腸炎に出現する異型上皮の病理組織学的判定基準—surveillance colonoscopyへの応用を目的とした新判定基準の提案.日本大腸肛門病会誌 47:547-551, 1994
7)味岡洋一,佐野知江.潰瘍性大腸炎における大腸癌の病理組織学的特徴と生検診断.日消誌 110:379-384, 2013
8)Murnyák B, Hortobágyi T. Immunohistochemical correlates of TP53 somatic mutations in cancer. Oncotarget 7:64910-64920, 2016
9)味岡洋一,谷優佑,高村佳緒里,他.炎症性発癌の病理診断と発癌機序.病理と臨 36:1076-1081, 2018
10)伴慎一,清水道生,山岸秀嗣,他.病理組織からみたcolitic cancerの初期病変.胃と腸 49:1407-1422, 2014
11)Shigaki K, Mitomi H, Fujimori T, et al. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia:neuroendocrine differentiation as an early event in the colitis-neoplasia sequence. Hum Pathol 44:2393-2399, 2013
12)Harpaz N, Polydorides AD. Colorectal dysplasia in chronic inflammatory bowel disease:pathology, clinical implications, and pathogenesis. Arch Pathol Lab Med 134:876-895, 2010
13)Okayasu I. Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence. Pathol Int 62:368-380, 2012
14)Chen R, Lai LA, Brentnall TA, et al. Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol 22:7882-7891, 2016
15)Robles AI, Traverso G, Zhang M, et al. Whole-exome sequencing analysis of inflammatory bowel disease-associated colorectal cancers. Gastroenterology 150:931-943, 2016
16)Dhir M, Montgomery EA, Glöckner SC, et al. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease(IBD)associated neoplasia. J Gastrointest Surg 12:1745-1753, 2008
17)田中正則.通常腺腫とcolitic cancer/dysplasiaの鑑別—生検を含む.胃と腸 37:971-979, 2002